β-defensin 1 Antibodies

Santa Cruz Biotechnology delivers a wide array of β-defensin 1 monoclonal antibodies for research focused on understanding this important antimicrobial peptide. β-defensin 1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-defensin 1 is a key component of the innate immune system, playing a crucial role in the defense against microbial infections. β-defensin 1 is primarily expressed in epithelial tissues and demonstrates the ability to disrupt microbial membranes, exhibiting potent antimicrobial activity. Research has shown that β-defensin 1 modulates immune responses through multiple pathways. Understanding β-defensin 1 function has significant implications for developing new therapeutic strategies. Current studies continue to reveal new aspects of β-defensin 1's role in maintaining immune homeostasis. β-defensin 1 research using Santa Cruz Biotechnology monoclonal antibodies contributes to advancing our understanding of immune defense mechanisms and potential therapeutic applications.